Miura Y, Ohkubo H, Nakano A, Bourke EJ, Kanazawa S.
Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung. Front. Immunol. 2022 Nov 4;13:1028613.
doi: 10.3389/fimmu.2022.1028613 PMID: 36405683
Miura Y, Isogai S, Maeda S, Kanazawa S.
CTLA-4-Ig internalizes CD80 in fibroblast-like synoviocytes from chronic inflammatory arthritis mouse model Sci Rep 2022 Sep 30;12(1):16363.
doi: 10.1038/s41598-022-20694-7. PMID: 36180526
Mikami S, Miura Y, Kondo S, Sakai K, Nishimura H, Kyoyama H, Moriyama G, Koyama N, Noguchi H, Ohkubo H, Kanazawa S, Uematsu K.Mikami S, Miura Y, Kondo S, Sakai K, Nishimura H, Kyoyama H, Moriyama G, Koyama N, Noguchi H, Ohkubo H, Kanazawa S, Uematsu K.
Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis-associated interstitial lung disease mice PLoS One 2022 Jun 17;17(6):e0270056.
doi: 10.1371/journal.pone.0270056 PMID: 35714115
Miura Y, Ohkubo H, Niimi A, Kanazawa S.
Suppression of epithelial abnormalities by nintedanib in induced-rheumatoid arthritis-associated interstitial lung disease mouse model ERJ Open Res. 2021 Dec 6;7(4):00345-2021.
doi: 10.1183/23120541.00345-2021 PMID: 34881329
Miura Y, Lam M, Bourke EJ, Kanazawa S.
Bimodal fibrosis in a novel mouse model of bleomycin-induced usual interstitial pneumonia Life Sci Alliance 2021 Nov 2;5(1):e202101059.
doi: 10.26508/lsa.202101059 PMID: 34728556
Miura Y, Kanazawa S.
Osteochondrogenesis derived from synovial fibroblasts in inflammatory arthritis model. Inflamm Regen. 2020 May 1;40:7.
doi: 10.1186/s41232-020-00115-w. PMID: 32377275
Terasaki Y, Terasaki M, Kanazawa S, Kokuho N, Urushiyama H, Kajimoto Y, Kunugi S, Maruyama M, Akimoto T, Miura Y, Igarashi T, Ohsawa I, Shimizu A.
Effect of H2 treatment in a mouse model of rheumatoid arthritis-associated interstitial lung disease. J Cell Mol Med. 2019 Oct;23(10):7043-7053.
Miura Y, Ohta S, Peterlin M, McDevitt G, Kanazawa S.
A subpopulation of synovial fibroblasts leads to osteochondrogenesis in a mouse model of chronic inflammatory rheumatoid arthritis. JBMR Plus 2019 Jan 15;3(6):e10132.
Fujikawa J, Takeuchi Y, Kanazawa S, Nomir A, Kito A, Elkhashab E, Ghaleb A, Yang V, Akiyama S, Morisaki I, Yamashiro T, Wakisaka S, Abe M.
Kruppel-like factor 4 regulates matrix metalloproteinase and aggrecanase gene expression in chondrocytes. Cell Tissue Res. 2017 Dec;370(3):441-449.
Kato Y, Oki K, Suga N, Ono S, Ishisaka A, Miura Y, Kanazawa S, Naito M, Kitamoto N, Kettle AJ.
A novel quinone derived from 5-hydroxyindoleacetic acid reacts with protein: Possible participation of oxidation of serotonin and its metabolite in the development of atherosclerosis. Free Radic Biol Med 2016; 101: 500-510.
Kawaguchi M, Hara N, Vladimir B, Koike H, Suzuki MK. Tae-Sun K, Nan G, Yu D, Sheng Z, Fujinawa Y, Yamamoto O, Ito H, Tomita Y, NaruseY, Sakamaki A, Ishii Y, Tsuneyama K, Inoue M, Itoh J, Yasuda M, Sakata N, Cha-Gyun J, Kanazawa S, Akatsu H, Minato H, Nojima T, Asai K, Miura Y.
A diagnostic marker for superficial urothelial bladder carcinoma: lack of nuclear ATBF1 (ZFHX3) by immunohistochemistry suggest malignant progression. BMC Cancer 2016; 16: 805. PMID 27756245
Zhang S, Kim TS, Dong Y, Kanazawa S, Kawaguchi M, Gao N, Minato H, Takegami T, Nojima T, Miura Y.
AT motif binding factor 1 (ATBF1) is highly phosphorylated in embryonic brain and protected from cleavage by calpain-1. Biochem Biophys Res Commun. 2012; 427: 537-541.
Murata M, Otsuka M, Mizuno H, Shiratori M, Miyazaki S, Nagae H, Kanazawa S, HamaokiM, Kuroki Y, Takahashi H.
Development of an ELISA for Measurement of Rat Pulmonary Surfactant Protein D Using Monoclonal Antibodies. Exp. Lung Res. 2010; 36, 463-468
Kanazawa S, Ota S, Sekine C, Tada T, Otsuka T, Okamoto T, Sounderstrup G, Peterlin BM.
Aberrant MHC class II expression in mouse joints leads to arthritis with extra-articular manifestations similar to rheumatoid arthritis. Proc Natl Acad Sci USA. 2006; 103, 14465-14470
Ota S, Kanazawa S, Kobayashi M, Otsuka T, and Okamoto T.
Establishment of a simple and quantitative immunospot assay for detecting anti-type II collagen antibody using infrared fluorescence imaging system (IFIS). J. Immunol. Methods. 2005; 299, 189-198
Kobayashi S, Kajino S, Takahashi N, Kanazawa S, Imai K, Hibi Y, Ohara H, Itoh M, and Okamoto T.
53BP2 induces apoptosis through the mitochondrial death pathway. Genes to Cells. 2005; 10, 253-260
Ando S, Kanazawa S, Tetsuka T, Ohta S, Jiang X, Tada T, Kobayashi M, Matsui N, Okamoto T.
Induction of Notch signaling by tumor necrosis factor in rheumatoid synovial fibroblasts. Oncogene 2003; 22: 7796-7803
Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F, Jablons DM.
Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res. 2003; 63, 4547-4551
Asamitsu K, Tetsuka T, Kanazawa S, Okamoto T.
RING finger protein AO7 supports the NF-kappaB-mediated transcription by interacting with the transactivation domain of p65 subunit. J. Biol. Chem. 2003; 278, 26879-26887.
Lin X, Irwin D, Kanazawa S, Huang L, Romeo J, Yen TS, Peterlin BM.
Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir. J Virol 2003; 77, 8227-8236.
Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin BM.
NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell. 2001; 8:327-337. DOI:10.1016/s1097-2765(01)00314-8
Kanazawa S, Peterlin BM.
Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes. Int Immunol. 2001;13:951-958.
Kanazawa S, Okamoto T, Peterlin BM.
Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity. 2000;12:61-70.
Fontes JD, Kanazawa S, Jean D, Peterlin BM. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol Cell Biol. 1999;19:941-947.
Ilic D, Kanazawa S, Nishizumi H, Aizawa S, Kuroki T, Mori S, Yamamoto T.
Skin abnormality in aged fyn-/- fak+/- mice. Carcinogenesis. 1997;18:1473-1476.
Kanazawa S, Ilic D, Hashiyama M, Okada M, Noumura T, Aizawa S, Suda T.
Impaired development of CD4+CD8+ thymoyctes by csk-'knock-in' into fyn locus. Oncogene. 1996;13:199-204.
Ilic D, Kanazawa S, Furuta Y, Yamamoto T, Aizawa S.
Impairment of mobility in endodermal cells by FAK deficiency. Exp Cell Res. 1996;222:298-303.
Kanazawa S, Ilic D, Hashiyama M, Noumura T, Yamamoto T, Suda T, Aizawa S.
p59fyn-p125FAK cooperation in development of CD4+CD8+ thymocytes. Blood. 1996;87:865-870.
Furuta Y, Ilic D, Kanazawa S, Takeda N, Yamamoto T, Aizawa S.
Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK. Oncogene. 1995;11:1989-1995.
Kanazawa S, Ilic D, Noumura T, Yamamoto T, Aizawa S.
Integrin stimulation decreases tyrosine phosphorylation and activity of focal adhesion kinase in thymocytest formation in cells from FAK-deficient mice. Nature. 1995;377:539-544.
Todokoro K, Kanazawa S, Amanuma H, Ikawa Y.
Characterization of erythropoietin receptor on erythropoietin-unresponsive mouse erythroleukemia cells. Biochim Biophys Acta. 1988;943:326-330.
Todokoro K, Kanazawa S, Amanuma H, Ikawa Y.
Specific binding of erythropoietin to its receptor on responsive mouse erythroleukemia cells. Proc Natl Acad Sci USA. 1987;84:4126-4130.
